SUDAFED DECONGESTANT CHILDREN'S CHEWABLE TABLETS 15 MG — DIN 02237301
PSEUDOEPHEDRINE HYDROCHLORIDE : 15 MG · PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is SUDAFED DECONGESTANT CHILDREN'S CHEWABLE TABLETS?
SUDAFED DECONGESTANT CHILDREN'S CHEWABLE TABLETS 15 MG contains PSEUDOEPHEDRINE HYDROCHLORIDE : 15 MG. It is listed in the Health Canada Drug Product Database under DIN 02237301, held by PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2006. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Pseudoephedrine cost around the world?
Pseudoephedrine is listed on 3 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; South Africa publishes a single exit price; United States publishes a acquisition. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 5 | 6 | ZAR███.██ |
| United States | acquisition | 2 | 3 | USD███.██ |
| Australia | ex-manufacturer | 2 | 2 | AUD███.██ |
11 pack listings across 9 brand entries and 3 price bases, refreshed 08 Sep 2026. Ranges span every Pseudoephedrine pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Pseudoephedrine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
16 holders have a Canadian DIN containing Pseudoephedrine, across 32 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| WARNER-LAMBERT CANADA INC. | 6 | 0 | SUDAFED DECONGESTANT 12 HOUR CAPLETS - 120MG, SUDAFED DECONGESTANT EXTRA STRENGTH TABLETS, SUDAFED DECONGESTANT REGULAR STRENGTH SYRUP, SUDAFED DECONGESTANT REGULAR STRENGTH TABLET | No marketed DIN |
| GLAXO WELLCOME INC. | 4 | 0 | SUDAFED NASAL COLD 12 HOUR CAPLETS, SUDAFED NASAL COLD EXTRA STRENGTH TABLETS, SUDAFED NASAL COLD REGULAR STRENGTH SYRUP, SUDAFED NASAL COLD REGULAR STRENGTH TABS | No marketed DIN |
| PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | 4 | 0 | BENYLIN D FOR INFANTS, PLUS SINUS, SUDAFED DECONGESTANT CHILDREN'S CHEWABLE TABLETS, SUDAFED DECONGESTANT EXTRA STRENGTH TABLET | No marketed DIN |
| BURROUGHS WELLCOME INC. | 2 | 0 | SUDAFED SYR 30MG/5ML, SUDAFED TAB 60MG | No marketed DIN |
| KV PHARMACEUTICAL COMPANY | 2 | 0 | MAXENAL SRC 240MG, PSEUDOEPHEDRINE HYDROCHLORIDE SRT 120MG TAB | No marketed DIN |
| NOVARTIS CONSUMER HEALTH CANADA INC. | 2 | 0 | TRIAMINIC ALLERGY CONGESTION, TRIAMINIC PEDIATRIC ORAL COLD DROPS - 7.5MG/0.8ML | No marketed DIN |
| SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | 2 | 0 | CONTAC COLD NONDROWSY CAPSULES, CONTAC-C NONDROWSY (SUSTAINED RELEASE CAP) | No marketed DIN |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 2 | 0 | CONGEST-EZE TAB 60MG, DECONGESTANT TABLETS | No marketed DIN |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | 1 | 0 | NON DROWSY REGULAR STRENGTH CONTAC COLD 12 HOUR | No marketed DIN |
| ICN CANADA LTD. | 1 | 0 | SUDODRIN TAB 60MG | No marketed DIN |
| MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 1 | 0 | MAXENAL CAPLET 120MG | No marketed DIN |
| ZEE MEDICAL | 1 | 0 | CONGEST AID TAB 30MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 15 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Pseudoephedrine |
|---|---|
| ATC code | R01BA02 |
| AHFS class | 12:12.12 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02237301 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2237301 |
| Brand name | SUDAFED DECONGESTANT CHILDREN'S CHEWABLE TABLETS |
| Generic / active ingredient | PSEUDOEPHEDRINE HYDROCHLORIDE : 15 MG |
| Market authorization holder | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA02 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01BA |
| Current status | CANCELLED POST MARKET |
| Status date | 03-Aug-2006 |
| Original market date | 1998-08-13 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 32 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| BALMINIL DECONGESTIONNANT SIROP 30MG/5ML | 30 MG / 5 ML | SYRUP | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | 00769592 |
| BENYLIN D FOR INFANTS | 7.5 MG / 0.8 ML | SYRUP | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | 02248007 |
| CONGEST AID TAB 30MG | 30 MG | TABLET | ZEE MEDICAL | CANCELLED POST MARKET | 00806838 |
| CONGEST-EZE TAB 60MG | 60 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 01950401 |
| CONTAC COLD NONDROWSY CAPSULES | 120 MG | CAPSULE (SUSTAINED-RELEASE) | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | 02230423 |
| CONTAC-C NONDROWSY (SUSTAINED RELEASE CAP) | 120 MG | CAPSULE (SUSTAINED-RELEASE) | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | 02082489 |
| DECONGESTANT TABLETS | 60 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 01950428 |
| ELTOR 120 SRT 120MG | 120 MG | TABLET (EXTENDED-RELEASE) | MERRELL DOW PHARMACEUTICALS (CANADA) INC. | CANCELLED POST MARKET | 01957481 |
| MAXENAL CAPLET 120MG | 120 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | 01958046 |
| MAXENAL SRC 240MG | 240 MG | CAPSULE (SUSTAINED-RELEASE) | KV PHARMACEUTICAL COMPANY | CANCELLED POST MARKET | 00817082 |
2 · Same class — other molecules in ATC R01BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Pseudoephedrine, Combinations | ACTIFED SYRUP · ACTIFED TABLETS · AERIUS DUAL ACTION 24 HOUR · AERIUS SINUS + ALLERGY · +25 more | 30 | 5 | Yes |
| Pseudoephedrine | BALMINIL DECONGESTIONNANT SIROP 30MG/5ML · BENYLIN D FOR INFANTS · CONGEST AID TAB 30MG · CONGEST-EZE TAB 60MG · +26 more | 32 | 0 | Not in Canada |
| Phenylpropanolamine, Combinations | BRONCHODEX D CAP · CHLOR TRIPOLON DECONGEST SYR · COLD & ALLERGY RELIEF - LIQ · COLD DECONGESTANT LONG ACTING CAP · +24 more | 28 | 0 | Not in Canada |
| Phenylephrine, Combinations | ACTIFED PE · CHILDREN'S BENADRYL-D SYRUP · COLD & STUFFY NOSE · COLD LIQUID · +19 more | 24 | 0 | Not in Canada |
| Phenylephrine | BENYLIN COLD STRIPS · BENYLIN D FOR INFANTS · HELP I HAVE A STUFFY NOSE · HELP I HAVE THE SNIFFLES · +9 more | 13 | 0 | Not in Canada |
| Sympathomimetics | EPHEDRINE HCL · EPHEDRINE HCL 8 MG · T-DRENE 1 | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is SUDAFED DECONGESTANT CHILDREN'S CHEWABLE TABLETS called?
The same molecule, Pseudoephedrine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Decofed | Latin | South Africa |
| Drilix | Latin | South Africa |
| Fludactil Co | Latin | South Africa |
| Sinutab Sinus Allergy Congestion | Latin | South Africa |
| Symptofed | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.